(1) Facilitate the initiation and conduct of observational research in Europe and propose mechanisms to support multinational and multidatabase studies |
(2) Improve the ENCePP code of conduct with additional tools to promote transparency, scientific independence, and good governance of pharmacoepidemiological research |
(3) Ensure that the ENCePP network remains focused on public health and supports health decision‐makers such as regulatory authorities, health technology assessment bodies, and public health institutions |
(4) Ensure that the network embraces relevant innovative data sources and areas of activity, eg, social media information and big data |
(5) Continue to support best methodological practices in the conduct of pharmacoepidemiology |
(6) Further develop the “pharmacovigilance” component of ENCePP and develop a methodological framework for measuring the public health impact of pharmacovigilance activities |